Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show.

Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia. Anticholinergics are a common class of drug that includes some allergy medications, sleeping pills and many more common medicines.

Dr. Campbell recently received a $3.3 million grant from the National Institute on Aging to conduct the first clinical trial designed to determine if stopping these medications results in sustained improvements in cognition.

Listen to his discussion with the Caregiver Crossing hosts and his advice for people who are taking these medications.

Segment 1

 

Segment 2

Click here for more information on Caregiver Crossing.

Related News

Jul 16, 2019 • Announcements, News
Expert in advance care planning named Director of Regenstrief’s Center for Aging Research
Susan Hickman, Ph.D., has been selected to lead the Indiana University Center for Aging Research at the Regenstrief Institute. She will be the second director in the center’s history. Dr. Hickman is a clinical geropsychologist focused on optimizing the quality of life for older adults through improved decision-making and communication about treatment preferences. Much of…
Continue Reading >
Jul 15, 2019 • News
Novel app designed to help patients avoid drugs linked to dementia
Researcher awarded $3.5 million to study effectiveness of technology intervention aimed at older adults A team of researchers from Indiana University School of Medicine, Regenstrief Institute and Purdue University, led by Richard Holden, PhD, is testing a new app, called Brain Safe, designed to help people reduce their exposure to a common class of drugs…
Continue Reading >